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ABSTRACT Monoclonal antibodies (mAbs) that react
with soluble mercuric ions have been produced by i 'ection of
BALB/c mice with a hapten-carrier complex designed to
maximize exposure of the metal to the immune system. Three
hybridomas producing antibodies that reacted with bovine
serum albumin (BSA)-glutathione-HgCI, but not with BSA-
glutathione, were isolated from the spleen of a mouse given
multiple iqjections with glutathione-HgCl conjugated to key-
hole limpet hemocyanin. Stable subclones were established
from two of these antibodies, designated mAb 4A10 and mAb
IF10. The binding of both antibodies to immobilized BSA-
glutathione-HgCl was inhibited by soluble HgCl2, and disso-
ciation constants for mercuric chloride binding were 2.3 and
3.7 nM for mAbs 4A10 and l10, respectively. Both antibodies
bound mercuric acetate with similar affinities, demonstrating
that the antibodies were capable of binding to mercuric ions in
the presence of a different counterion than the one used in the
immunogen. Reactions were not observed with other metal
cations by either antibody. These data demonstrate the suc-
cessful induction of antibodies that react very specifically with
mercuric ions in solution regardless ofthe presence ofa carrier.
The most vigorous immune responses are induced by large
molecular weight, structurally complex molecules with a high
degree of foreignness for the stimulated recipient. An im-
mune response to a small, relatively simple compound,
known as a hapten, can also be induced by linking it to an
immunogenic carrier, usually a protein, before injection.
Even then, there appear to be limits to the types of molecules
that can induce specific responses, in that most of the
commonly used haptens for classical immunological studies
have contained aromatic rings or charged, polar regions, as
exemplified by nitrophenyl derivatives and phosphocholine.
Smaller, less complex molecules, such as metals or metallic
ions, have not been considered to be of sufficient size or
complexity to induce the formation of specific antibodies.
This belief has been held despite the fact that small molecules
in general, and metals in particular, have long been known to
induce cell-mediated immunity, as in contact hypersensitiv-
ity (1), and that other proteins, such as enzymes, can dem-
onstrate specificity with respect to metal binding. Further-
more, exposure to heavy metals, such as lead and mercury,
can induce autoimmune disease in genetically predisposed
strains of mice and rats (2), and observations by several
investigators have suggested that metal ions affect the spec-
ificity of antibodies produced against proteins or haptens to
which the metals are bound (3-9). Finally, it was noted
several years ago that myeloma patients with hypercupremia
and hypercalcemia produced antibodies that bound copper
and calcium (10, 11).
These observations indicate that metals can at least influ-
ence antibody specificity and, rarely, in immunopathological
conditions, can serve as haptens toward which an antibody
response can be directed. This report describes the produc-
tion of monoclonal antibodies (mAbs) specific for soluble
mercuric ions by immunization of BALB/c mice with a
complex consisting of mercuric chloride-glutathione-
keyhole limpet hemocyanin (KLH).
MATERIALS AND METHODS
Mice. BALB/c mice were obtained from the animal colony
ofthe School of Biological Sciences, University ofNebraska,
which was established with breeders from The Jackson
Laboratory.
Antigen Preparation. Glutathione was first conjugated to
KLH or bovine serum albumin (BSA) with 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide hydrochloride as de-
scribed (12). After dialysis against phosphate-buffered saline
(PBS), 3 ml of glutathione-BSA or glutathione-KLH was
added dropwise to 25 ml of 1 mM HgCl2 in water while
stirring. The solution was then dialyzed overnight against one
change ofPBS and two changes of water. Atomic absorption
analysis revealed 38 mol of mercury per 400 kDa ofKLH and
8 mol of mercury per mol of BSA.
Mouse Immunization and Hybridoma Production. BALB/c
mice were given five intraperitoneal injections at 2-week
intervals with 50 pug of KLH-glutathione-HgCl per injection.
Antigen was emulsified in complete Freund's adjuvant for the
first two injections and in either incomplete Freund's adju-
vant or PBS for all subsequent injections.
One week after the fifth injection, a drop of blood was
collected from the tail vein ofeach mouse into 0.45 ml ofPBS.
This was considered a 1:10 dilution, which was diluted
10-fold further in PBS containing 2% BSA prior to ELISA as
described below.
Before fusion for hybridoma production, a mouse was
injected intraperitoneally with 10 ,ug of KLH-glutathione-
HgCl in PBS. Four days later, its spleen was used for fusion
as described (13).
For production of ascites fluid, 5 x 106 hybridoma cells
were injected into the peritoneal cavity of a BALB/c mouse
that had been primed with pristane 7-60 days earlier. Ascites
fluid was harvested 1-2 weeks after injection.
ELISA. Microtiter plates to which either BSA-glutathione
or BSA-glutathione-HgCl had been adsorbed were blocked
by incubation for 2 hr at room temperature with 5% nonfat
dry milk in PBS. One hundred microliters of culture fluid or
serum was added to the appropriate well and incubated for 2
hr at room temperature. The plate was then washed three
times with ELISA wash (0.1% Nonidet P40 in PBS), fol-
Abbreviations: BSA, bovine serum albumin; KLH, keyhole limpet
hemocyanin; mAb, monoclonal antibody.
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lowed by addition of 100 Al of goat anti-mouse antiserum
(Cappel Laboratories). The plate was incubated and washed
as described above; then 100 pl of rabbit anti-goat antiserum
conjugated with alkaline phosphatase (Sigma) was added.
After a 2-hr incubation at room temperature, the plate was
washed three times with ELISA wash followed by 5-10
rinses under gently running tap water. One hundred micro-
liters of 2 mMp-nitrophenyl phosphate in 1 M diethanolamine
(pH 9.6) containing 25 mM MgCl2, was added, and the A405
of each well was measured after incubation at room temper-
ature for 15-30 min.
Inhibition of Antibody Binding by Soluble Mercuric Chlo-
ride. Fifty microliters of various concentrations of mercuric
chloride from 20 mM to 20 pM in PBS, in addition to 50 ,ul of
diluted ascites fluid containing either mAb 4A10 or mAb
iF10, was added to appropriate wells of a microtiter plate to
which BSA-glutathione-HgCl had been adsorbed. The plate
was incubated at room temperature for 30 min, then rinsed
three times with ELISA wash. One hundred microliters of
horseradish peroxidase-conjugated goat antiserum specific
for mouse IgM, IgG, and IgA (Kirkegaard and Perry Labo-
ratories, Gaithersburg, MD) was added, and the plate was
processed through the ELISA procedure described above.
The inhibition of antibody binding for each mercuric chlo-
ride concentration was calculated according to the following
formula:
% inhibition =
{1 - [(A405 of exp - A405 of neg)/(A405 of pos
- A405 of neg)]} x 100.
The negative (neg) control consisted of wells containing a
mAb specific for dinitrophenol instead of mAb 4A10 or mAb
iF10, while for the positive (pos) control, the PBS added to
the wells contained no mercuric chloride.
Determination of the Dissociation Constant of Mercury-
Specific Antibodies. The dissociation constants of mAb 4A10
and mAb iF10 for mercuric chloride and other metals were
determined by the procedure of Friguet et al. (14). Two-fold
dilutions of each metal salt from 10 AuM to =10 pM were used
in these experiments. The wells of a microtiter plate con-
taining no antigen were blocked with nonfat dry milk. Fifty
microliters of diluted ascites fluid was added to 50 ,l of
various concentrations of the metal salt being tested for
antibody binding. The metal and antibody mixture was in-
cubated for 1 hr at room temperature and then transferred to
A
a microtiter plate containing adsorbed BSA-glutathione-
HgCI.
The metal/antibody solution was incubated in this plate for
60 min, after which the plate was washed as described above,
and 100 Al of horseradish peroxidase-conjugated goat anti-
serum specific for mouse IgM, IgG, and IgA was added. After
incubation for 15 min at room temperature, the A405 was
measured. Preliminary experiments demonstrated that no
readjustment of the antigen-antibody equilibrium in the liq-
uid phase occurred in the coated wells with the conditions
under which these experiments were carried out (data not
shown). The dissociation constants ofthe antibodies for each
metal were then calculated from the slopes of the Klotz plots,
as described (14).
RESULTS
To increase the likelihood of inducing mercury-specific an-
tibodies, a hapten-carrier complex was designed that would
maximize the exposure of the mercury, making it more likely
that the metal itself would be recognized as a distinct entity
by the immune system. It was felt that the use of chelating
agents, in which the metal is part of a multidentate complex
inside a latticework with multiple interactions between it and
the functional groups of the chelating agent (Fig. 1A and ref.
15), would lead to production of antibodies specific for the
conformation of the chelating agent imparted to it by the
metal. In this case, an antibody produced against a metal-
chelate complex would probably recognize the chelating
agent when it contains any metal that imparts a conformation
similar to the one it assumed when used for antibody induc-
tion.
The strategy devised for this study involved the use of
glutathione, which is a tripeptide of 'y-L-glutamyl-L-
cysteinylglycine, as a carrier for mercury. Because of the
high affinity of mercury for sulfhydryl groups (17), no other
functional groups in the peptide or protein would be required
for maintenance ofthe cysteine-mercury complex (16). Thus,
a mercuric ion in the proper molecular environment would be
bound to the complex by interaction with only the -SH group
of a single cysteine residue (Fig. 1B). The presentation of
Hg2" to the immune system as a monodentate ligand might
allow selection of antibodies whose binding sites contain
additional ligands that can interact with the remainder of the
coordination sphere of the metal.
To test the feasibility of this approach, eight BALB/c mice
were given five intraperitoneal injections of KLH-
B
- Glutathione
KLH
FIG. 1. Schematic diagrams of mercuric ions coordinated to EDTA and glutathione. (A) Representation of the coordination of mercury to
EDTA as a sexadentate ligand, adapted from Mellor (15). The bonds between the atoms comprising a girdle around the mercury atom are
represented by thick lines, while the other bonds are represented as thinner lines to maintain a three-dimensional effect. (B) Representation of
mercury as a monodentate ligand coordinately bound to the sulfhydryl group of the cysteine residue of glutathione. The binding of mercury to
glutathione via only the sulfhydryl group is based on data of Fuhr and Rabenstein (16).
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glutathione-HgCl at 2-week intervals. One week after the
fifth injection, blood was collected from the tail vein of each
mouse and assayed by ELISA for the presence of mercury-
specific antibodies. Table 1 shows the reactivity of each
serum sample with BSA-glutathione and BSA-glutathione-
HgCl, along with the difference in reactivity. Sera from five
of the eight mice (nos. 2, 4, 5, 6, and 7) demonstrated higher
reactivity with BSA-glutathione-HgCl than with BSA-
glutathione, suggesting that they might contain antibodies
specific for either Hg2+ itself or for an epitope composed of
both Hg2+ and glutathione.
Since mouse 6 demonstrated the highest relative reactivity
with BSA-glutathione-HgCl, it was given an intraperitoneal
injection of 10 ,g of KLH-glutathione-HgCl in PBS, and its
spleen was used 4 days later for fusion. One hundred thirty-
four hybridomas were obtained and screened by ELISA for
reactivity with BSA-glutathione-HgCl and BSA-glu-
tathione. The results were compared to the reactivity of a
dinitrophenol-specific mAb with the same antigens, which
served as the negative control. Four antibodies (lH11, 2A9,
3A12, and 3H9) reacted with both BSA-glutathione-HgCl
and BSA-glutathione, as evidenced by A405 values 2-4 times
above background (Table 2). Three other antibodies (ilFO,
3E8, and 4A10) reacted strongly with BSA-glutathione-HgCl
but showed only background reactivity with BSA-
glutathione. These antibodies were considered presump-
tively specific for HgCl2 or HgCl-glutathione. Stable sub-
clones were established from iF10 and 4A10 by limiting
dilution for further characterization.
The reactivity of these antibodies with only BSA-
glutathione-HgCI indicated that mercuric ions constituted
the epitope, or at least an important part of the epitope,
recognized by the antibodies. To investigate whether the
antibodies would react with mercuric chloride alone, 10-fold
dilutions of HgCl2 from 10 mM to 10 pM were used to inhibit
antibody binding to BSA-glutathione-HgCl adsorbed to the
wells of a microtiter plate (Fig. 2). The binding of both
antibodies to adsorbed antigen was inhibited by soluble
HgCl2, with 50% inhibition between 1 and 0.1 nM HgCl2 for
each. The specificity of the inhibition was demonstrated by
the inability of the same concentrations of mercuric chloride
to inhibit the binding of an asparagine synthetase-specific
mAb (mAb 3D11) to asparagine synthetase. These data
demonstrated that reactivity of both antibodies with HgCl2
was independent of the presence of either glutathione or the
carrier.
Table 1. Reactivity of serum from BALB/c mice injected with
BSA-glutathione (GSH)-HgCl
BSA-GSH- %
Mouse BSA-GSH* HgCl* differencet
1 1.332 1.214 -8.9
2 0.808 0.886 +9.7
3 2.382 1.505 -36.8
4 0.654 0.947 +44.8
5 0.682 0.848 +24.3
6 0.453 0.756 +66.9
7 0.567 0.865 +52.6
8 1.670 1.456 -12.8
Normal serum 0.299 0.308 +3.0
One drop of blood was collected from the tail vein of each mouse
into 0.45 ml of PBS, which was assumed to be a 1:10 dilution. A
10-fold dilution of this was made in 2% BSA in PBS and was used for
ELISA as described. Normal serum was obtained from an unimmu-
nized mouse and served as background reactivity for each antigen.
*A405 of a 1:100 dilution of serum from each mouse when assayed by
ELISA against the indicated antigen. Each number represents the
average of triplicate determinations.
tCalculated by the formula % difference = [(A405 of BSA-GSH-Hg
- A405 of BSA-GSH)/(A405 of BSA-GSH)] x 100.
Table 2. Reactivity of hybridoma antibodies with
BSA-glutathione-HgCl and BSA-glutathione
BSA-
glutathione- BSA-
Hybridoma HgCl glutathione
1H11 1.246 1.202
2A9 0.758 1.052
3A12 1.792 2.127
3H9 1.606 2.134
iOlO 1.175 0.406
3E8 1.076 0.410
4A10 1.104 0.400
NC 0.428 0.456
Fifty microliters of culture fluid was assayed for the presence of
antibody specific for the antigen shown. Each value represents the
average A4,5 of triplicate determinations for each antibody. The
negative control (NC) consisted of an antibody specific for dinitro-
phenol. The A405 obtained with this antibody was considered back-
ground reactivity.
These results showed clearly that antibodies capable of
reacting with soluble mercuric chloride could be induced by
immunization with an appropriate antigen. The existence of
metal-binding proteins, however, is not unusual. In most
cases, though, these proteins bind very strongly to their
native metals, but other metals will bind with lower affinity.
Therefore, it was of interest to determine the affinity of the
antibodies for mercuric ions as well as to identify other metals
that might bind. The other metal salts used for these analyses
included barium chloride, cadmium chloride, chromic chlo-
100.
80*
c
0
.0
60*
40-
20
0-
mAb 4A1 0
mAb 1FlO
mAb 3D1 1
-2
-4 -6 -8 -10
Log [Hg2+]
FIG. 2. Inhibition of binding of mAb 4A10 and mAb iOlO to
immobilized BSA-glutathione-HgCl by soluble mercuric chloride.
Fifty microliters of each concentration of mercuric chloride and 50
,ul of diluted ascites fluid containing the indicated antibody were
incubated for 30 min at room temperature in the wells of a microtiter
plate containing adsorbed BSA-glutathione-HgCl. The plates were
then washed and horseradish peroxidase-conjugated goat anti-mouse
antiserum was added. After incubation and washing as described
above, 2,2'-azinobis(3-ethylbenzthiazoline sulfonate) substrate was
added, and the A405 was measured after 15 min. Each point repre-
sents the average of triplicate determinations. Percentage inhibition
was calculated as described. The positive control consisted of wells
containing 50 pl of PBS without mercuric chloride, and the negative
control consisted of wells containing a dinitrophenol-specific mAb
instead ofmAb 4A10 ormAb iOlO. mAb 3D11 is an antibody specific
for bovine asparagine synthetase, whose production and character-
ization have been described (18).
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ride, copper chloride, ferrous sulfate, gold chloride, mercuric
acetate, nickel chloride, selenium oxide, silver chloride, and
zinc chloride.
The dissociation constant of mAb 4A10 for HgCl2 was 2.3
± 0.8 nM, while that of mAb iF10 was 3.7 ± 1.5 nM (Table
3). Neither antibody bound any of the other metals to a
detectable extent. Since the highest concentration of each
metal salt used in these experiments was 10 gM, the disso-
ciation constants of both antibodies for the other metals was
at least 3-4 orders of magnitude higher than for mercury. In
addition, the antibodies did not bind to glutathione-HgCl any
more strongly than they did to HgCl2 (data not shown),
demonstrating that glutathione does not increase the strength
of the binding of mercury to the antibody and, thus, probably
does not bind to the antibody.
Table 3 also includes the dissociation constants of both
antibodies for mercuric acetate. As can be seen, the affinity
of mAb 4A10 for mercuric acetate was 4.1 ± 0.1 nM, while
that of mAb iF10 was 8.2 ± 2.5 nM. These results clearly
indicate that the mercuric ion itself is the major epitope
recognized by these antibodies, regardless of the counterion
originally present in the mercury-containing compound being
assayed for antibody reactivity.
DISCUSSION
Although metal-binding proteins occur widely in nature,
metals are generally considered incapable of eliciting a spe-
cific antibody response under normal conditions, although,
as mentioned above, they can affect the specificity of anti-
body responses to some metalloproteins and can also elicit
cell-mediated immunity. In addition, antibody light chains
can be modified to coordinate zinc for use in antibody-
mediated catalysis (19).
The results presented here, however, demonstrate clearly
that, under appropriate conditions, mercuric ions can induce
extremely specific antibodies that exhibit no detectable
cross-reactivity with other metals and bind mercuric chloride
with a high affinity, even when it is not conjugated to a large
molecular weight carrier. The sensitivity of these antibodies
has recently been demonstrated by their ability to detect
mercuric ions at a concentration of 0.2 ppb in 100 Aul of water
(20).
Table 3. Dissociation constants of mAb 4A10 and mAb 1F10 for
various metal salts
Metal salt mAb 4A10 mAb lF10
HgCl2 2.3 + 0.8 x 10-9 3.7 ± 1.5 x 10-9
BaC12 >1 X 10-5 >1 X 10-5
CdC12 >1 X 10-5 >1 X 10-5
CrC13 >1 X 10-5 >1 X lo-,
CuCl2 >1 X 10-5 >1 X 10-5
AuC13 >1 x 10-5 >1 X 10-5
FeSO4 >1 X iO-5 >1 X i0-5
NiCl2 >1 X lo-, >1 X 10-5
SeO2 >1 X 10-5 >1 X 10-5
AgNO3 >1 x l0o- >1 X 10-5
HgOAc 4.1 ± 0.1 x 10-9 8.2 ± 2.5 x 10-9
Two-fold dilutions of each metal salt from 10 ,M to -10 pM were
used in these experiments. The wells of a microtiter plate containing
no antigen were blocked with nonfat dry milk. Fifty microliters of
diluted ascites fluid was added to 50 ul of various concentrations of
the metal salt being tested for antibody binding. The metal solution
and the antibody were incubated for 1 hr at room temperature and
then transferred to a microtiter plate containing adsorbed BSA-
glutathione-HgCl and analyzed by ELISA as described. The disso-
ciation constants of the antibodies for each metal were then calcu-
lated from the slopes of the Klotz plots as described (14). Each value
represents the average derived from four separate experiments, each
done in duplicate.
It seems likely that the successful induction of metal-
specific antibodies was due to the method by which the metal
ions were presented to the immune system. Other investiga-
tors have used metal-chelate complexes for induction of
metal-specific antibodies. However, in this case, the chelat-
ing compound surrounds the metal with a cage-like structure
(Fig. 1A; see also ref. 15). It seems likely under these
conditions that the immune system would respond to the
conformation of the complex imparted to it by the particular
metal bound. In this scenario, the role of the metal in the
antigen-antibody interaction would be an indirect one, in
which it determines the shape of the complex without nec-
essarily coming into direct physical contact with the antigen-
binding site. If this were the case, an antibody specific for
either a metal-chelate complex or a protein containing a
highly coordinated metal would bind when the epitope con-
tains a metal that imparts the same conformation as the one
present when the complex was used for antibody induction.
This prediction seems to be borne out by patterns of cross-
reactivity reported for antibodies to porphyrins (21), metal-
chelate complexes (9, 22), and other metal-binding proteins
(3, 5). These antibodies bind most strongly with the complex
containing the metal present when used for immunization,
but they will cross-react when other metals are bound to the
complex.
In contrast to the situation discussed above for chelating
agents, peptides or proteins containing cysteine residues can
be used as the carrier for mercuric salts because of the high
affinity of mercury and its derivatives for sulfhydryl groups
(17). Therefore, if glutathione or another cysteine-containing
peptide were used as a carrier, a mercuric ion in the proper
milieu could be bound to the complex by interaction with only
the -SH group of a single cysteine residue. Such a situation
would maximize the exposure of the mercuric ion and in-
crease the probability that the metal would be perceived as a
distinct entity by the immune system and not simply as a
component of a larger epitope. This does not mean to imply
that this is the only way in which mercuric ions are bound in
the protein complex used for immunization. In actuality, they
probably exist in all possible coordination states, but perhaps
only those bound to a single sulfhydryl group can induce
antibodies with the specificity described here.
From the standpoint of metalloprotein chemistry, the af-
finity of these antibodies for Hg2+ is not without precedent,
since it is approximately of the same magnitude as carboxy-
peptidase A for its native metal Zn2+ (23). However, as most
metalloproteases bind a multiplicity of metal ions, the sin-
gular specificity of the antibodies for Hg2+ is highly unusual.
From an immunological standpoint, the affinity of the
interaction between the antibodies and mercuric ions is high
for such a simple hapten. Generally, affinities of hapten-
specific antibodies are 2-4 orders of magnitude lower than
those reported here, although the affinities of some of the
more tightly binding fluorescein-specific mAbs are similar to
these (24).
It is difficult to envision the factors responsible for the
specificity of the interaction between the antibodies and a
molecule so small as a mercuric ion, since the area of the
antigen-binding sites of antibodies ranges from 160 to goo A2
(25), and the diameter of a mercuric ion is only 2.2 A (26). The
specificity of these antibodies suggests that sulfhydryl groups
are not involved in the interaction, since reactivity with other
sulfhydryl-reactive metals, such as silver, cadmium, and
lead, was not observed. However, since mercury derivatives
have an extremely high affinity for sulfhydryl groups, with
dissociation constants as low as 10-42 (17), it is possible that
a partially occluded sulfhydryl group could be present in the
antigen-binding site and that only mercury, because of its
affinity, can react with it. The basis of the interaction
between mercuric ions and the antigen-binding site should
Immunology: Wylie et al.
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become more evident when the variable regions of the heavy
and light chains have been characterized.
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